By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aerie (AERI) To Announce First Quarter 2015 Financial Results And Host Conference Call On Thursday, May 7, 2015 4/29/2015 12:10:06 PM
Aerie (AERI) Reports Initial Rhopressa Phase III Efficacy Results 4/24/2015 5:49:59 AM
Aerie (AERI) Freefalls Aftermarket as Rhopressa Fails Phase III Study 4/23/2015 8:29:33 PM
Aerie Pharmaceuticals, Inc. (AERI) To Present At The 14th Annual Needham Healthcare Conference 4/8/2015 9:59:57 AM
Aerie Pharmaceuticals, Inc. (AERI) Completes Enrollment In Second Phase 3 Registration Trial (“Rocket 2”) Of Rhopressa, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma 3/24/2015 11:02:12 AM
Aerie Pharmaceuticals, Inc. (AERI) To Participate In Two Investor Conferences In March 3/3/2015 12:02:18 PM
Aerie Pharmaceuticals, Inc. (AERI) Announces Rhopressa Presentation At 2015 Meeting Of The Association For Ocular Pharmacology And Therapeutics 2/18/2015 1:40:45 PM
Aerie Pharmaceuticals, Inc. (AERI) Announces Potential Breakthroughs With New Preclinical Research 2/18/2015 10:42:04 AM
Aerie Pharmaceuticals, Inc. (AERI) To Announce Fourth Quarter And Year End 2014 Financial Results And Host Conference Call On Monday, March 2, 2015 2/17/2015 12:26:21 PM
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs 2/10/2015 7:05:24 AM
123456
//-->